Continuation of the nuMoM2b Heart Health Study
Part of paid clinical trials in Orange, California.
- Sponsor
- RTI International
- Study ID
- NCT05472597
- Status
- Enrolling By Invitation
Conditions
- Cardiovascular Diseases
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in U.S. women at all ages, and large knowledge gaps exist in CVD predictive and preventative strategies for women. The nuMoM2b Heart Health Study (nuMoM2b-HHS) has followed a demographically diverse cohort of women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospectively collected for up to 7 years thereafter. The overarching scientific goal of this study is to define the relationship between adverse pregnancy outcomes (APOs) and CVD to optimize CVD prediction, prevention, and treatment strategies for women. Continued follow-up of this observational cohort, building on a foundation of existing high-quality data, biospecimens, and administrative structures with a robust framework for ancillary study development and implementation, provides a unique opportunity to address knowledge gaps regarding the early mechanisms and trajectory of CVD in women.
Key Dates
- Start date
- Nov 29, 2022
- Status verified
- Oct 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 4,048 participants (estimated)
Arms
- Arm: nuMoM2b Heart Health Study CohortA large and diverse (both geographically and demographically) group of adult women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospective collected thereafter.
Primary Outcome Measure
Incidence of hypertension (130/80 mmHg) [ Time Frame: Assessed during the HHS2 in-person visit, 8-16 years after the index pregnancy. ]
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, Irvine Medical Center | Orange | California | 92868 | - |
| Christiana Care Health Services | Newark | Delaware | 19718 | - |
| Northwestern University | Chicago | Illinois | 60611 | - |
| Indiana University | Indianapolis | Indiana | 46202 | - |
| Columbia University Medical Center | New York | New York | 10032 | - |
| The MetroHealth System | Cleveland | Ohio | 44109 | - |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| Pennsylvania Hospital | Philadelphia | Pennsylvania | 19107 | - |
| UPMC Magee Womens Hospital | Pittsburgh | Pennsylvania | 15213 | - |
| Intermountain Medical Center | Murray | Utah | 84107 | - |
| McKay-Dee Hospital | Ogden | Utah | 84403 | - |
| Utah Valley Hospital | Provo | Utah | 84604 | - |
| LDS Hospital | Salt Lake City | Utah | 84143 | - |
| University of Utah | Salt Lake City | Utah | 84132 | - |
Find similar trials in Orange, CA
Related Studies
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Food and Microbiome Longitudinal Investigation (FAMiLI)Recruiting · NYU Langone Health · New York, New York
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama